InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Conditions:   Cancer Risk;   Cancer Predisposition Syndrome;   Hereditary Cancer Prediction;   Childhood Cancer Survivors;   Adult Cancer Survivors;   IARC Carcinogens;   Smoking History;   Lung Cancer;   Ductal/Lobular Carcinoma;   Barrett Esophagus;   Pancreatic Precursor Lesions;   Colonic Dysplasia/Adenomata;   Non-Alcoholic Fatty Liver Disease;   Non Alcoholic Steatohepatitis;   Cirrhosis;   High Grade Prostatic Epithelial Neoplasia;   High-grade Bladder Urothelial Dysplasia/Carcinoma in Situ;   Adenomatous Hyperplasia;   High-risk Oral Precancerous D iseases;   Melanocytic Lesion, Adult;   Hematologic Malignancy;   Lung; Node;   Serous Tubal Intraepithelial Carcinoma;   Endometrial Intraepithelial Neoplasia;   Cervical and Endocervical Carcinoma in Situ;   Vulvar Intraepithelial Neoplasia;   Nephrogenic Rests;   Benign Bone Lesions With Risk of Malignant Degeneration;   Giant Cell Tumor;   Osteochondroma;   Spitz Nevus Intervention:   Other: Samples Sponsor:   Dana-Farber Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials